Risk factors for posterior synechiae of the iris after 23-gauge phacovitrectomy
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Oh, Jong-Hyun | - |
dc.contributor.author | Na, Jaehoon | - |
dc.contributor.author | Kim, Seong-Woo | - |
dc.contributor.author | Oh, Jaeryung | - |
dc.contributor.author | Huh, Kuhl | - |
dc.date.accessioned | 2021-09-05T04:03:06Z | - |
dc.date.available | 2021-09-05T04:03:06Z | - |
dc.date.created | 2021-06-15 | - |
dc.date.issued | 2014-10-18 | - |
dc.identifier.issn | 2222-3959 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/97080 | - |
dc.description.abstract | AIM: To identify risk factors for the development of posterior synechiae of the iris (PSI) after 23 -gauge phacovitrectomy. METHODS: A retrospective chart review was performed in consecutive Asian patients treated with 23 -gauge phacovitrectomy with a 3-piece intraocular lens (IOL) or a single-piece 4 haptics IOL. RESULTS: A total of 263 eyes from 242 patients were included in the study. Postoperative PSI was identified in 16 (6.1%) eyes. In multivariate analysis, C3F8 gas tamponade, oil tamponade, and long operation time were significantly associated with PSI formation. There was no difference in the incidence of PSI between the groups using two different types of IOL (P=0.779). CONLUSION: C3F8 gas or oil tamponade and long operation time increased the incidence of PSI after 23 -gauge phacovitrectomy. The single-piece 4 haptics IOL, in lieu of a 3-piece IOL, may be inserted into the capsular bag with a comparable incidence of PSI. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | IJO PRESS | - |
dc.subject | PARS-PLANA VITRECTOMY | - |
dc.subject | INTRAOCULAR-LENS IMPLANTATION | - |
dc.subject | PROLIFERATIVE DIABETIC-RETINOPATHY | - |
dc.subject | CATARACT-SURGERY | - |
dc.subject | 20-GAUGE VITRECTOMY | - |
dc.subject | PHACOEMULSIFICATION | - |
dc.subject | COMPLICATIONS | - |
dc.subject | OUTCOMES | - |
dc.subject | SERIES | - |
dc.title | Risk factors for posterior synechiae of the iris after 23-gauge phacovitrectomy | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Seong-Woo | - |
dc.contributor.affiliatedAuthor | Oh, Jaeryung | - |
dc.contributor.affiliatedAuthor | Huh, Kuhl | - |
dc.identifier.doi | 10.3980/j.issn.2222-3959.2014.05.19 | - |
dc.identifier.wosid | 000343272900019 | - |
dc.identifier.bibliographicCitation | INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, v.7, no.5, pp.843 - 849 | - |
dc.relation.isPartOf | INTERNATIONAL JOURNAL OF OPHTHALMOLOGY | - |
dc.citation.title | INTERNATIONAL JOURNAL OF OPHTHALMOLOGY | - |
dc.citation.volume | 7 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 843 | - |
dc.citation.endPage | 849 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.relation.journalResearchArea | Ophthalmology | - |
dc.relation.journalWebOfScienceCategory | Ophthalmology | - |
dc.subject.keywordPlus | PARS-PLANA VITRECTOMY | - |
dc.subject.keywordPlus | INTRAOCULAR-LENS IMPLANTATION | - |
dc.subject.keywordPlus | PROLIFERATIVE DIABETIC-RETINOPATHY | - |
dc.subject.keywordPlus | CATARACT-SURGERY | - |
dc.subject.keywordPlus | 20-GAUGE VITRECTOMY | - |
dc.subject.keywordPlus | PHACOEMULSIFICATION | - |
dc.subject.keywordPlus | COMPLICATIONS | - |
dc.subject.keywordPlus | OUTCOMES | - |
dc.subject.keywordPlus | SERIES | - |
dc.subject.keywordAuthor | complication | - |
dc.subject.keywordAuthor | intraocular lens | - |
dc.subject.keywordAuthor | phacoemulsification | - |
dc.subject.keywordAuthor | vitrectomy | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.